- Record: found
- Abstract: not found
- Article: not found
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
Adie Viljoen, Camilla Andreassen, Andrea Navarria, Jörg Lüdemann, Ildiko Lingvay, Richard Pratley, Vanita Aroda
2018-02-01
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.